US Supply Of OTC COVID-19 Tests Gets Boost Through $231.8M Contract For Australian Firm

Biden administration seems to be betting Elluve's OTC at-home antigen diagnostic test will be a game changer in helping stop the spread of the coronavirus.

The Biden administration has given Ellume $213.8M to build a factory in the US to produce their at-home OTC COVID-19 test.
The Biden administration awards contract for supply of Ellmune's COVID-19 Home Test. • Source: Source: Shutterstock / Ellume Health (Shutterstock)

The US is paying digital diagnostics firm Ellume Ltd. $231.8m to to build a factory to boost production of its COVID-19 at-home diagnostic test that provides results in 15 minutes and is available nonprescription.

Until the facility is built for the Australian firm's Ellume USA LLC business based in Valencia, CA, the US will receive half the tests it

More from Asia

More from Geography